Back
Livento Group, Inc. Vs. Ultragenyx Pharmaceutical, Inc. Sector Stock Comparison
Sell
20
NUGN
Livento Group, Inc.
Last Price:
$0.0000
Seasonality Move:
0.6%
Sell
23
RARE
Ultragenyx Pharmaceutical, Inc.
Last Price:
$33.21
Seasonality Move:
6.21%
Sell
20
Livento Group, Inc. (NUGN)
is a Sell
Is Livento Group, Inc. a Buy, Sell or Hold?
-
The current Livento Group, Inc. [NUGN] share price is $0.0026. The Score for NUGN is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
NUGN is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
23
Ultragenyx Pharmaceutical, Inc. (RARE)
is a Sell
Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $33.21. The Score for RARE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NUGN Stock Price Chart
What is Livento Group, Inc.'s stock price today?
-
The Livento Group, Inc. share price today is $0.0026Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NUGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical, Inc.'s stock price today?
-
The Ultragenyx Pharmaceutical, Inc. share price today is $33.21Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
NUGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 43.18 | Sell |
| Chaikin Money Flow: | 1021500 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.0024 - 0.0024) | Buy |
| Bollinger Bands (100): | (0.0031 - 0.0031) | Sell |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.65 | Buy |
| Relative Strength Index (14 RSI): | 43.13 | Sell |
| Chaikin Money Flow: | -1062961 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.65 - 35.95) | Sell |
| Bollinger Bands (100): | (29.01 - 34.13) | Buy |
NUGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0 | Sell |
| 20-day SMA: | 0 | Sell |
| 50-day SMA: | 0 | Sell |
| 200-day SMA: | 7.46 | Sell |
| 8-day EMA: | 0 | Buy |
| 20-day EMA: | 0 | Buy |
| 50-day EMA: | 0 | Buy |
| 200-day EMA: | 0 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.62 | Sell |
| 20-day SMA: | 34.63 | Sell |
| 50-day SMA: | 33.66 | Sell |
| 200-day SMA: | 33.65 | Sell |
| 8-day EMA: | 7.38 | Buy |
| 20-day EMA: | 3.16 | Buy |
| 50-day EMA: | 1.3 | Buy |
| 200-day EMA: | 0.33 | Buy |
Livento Group, Inc. Earnings Growth & NUGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.
Livento Group, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||